Literature DB >> 20065006

Severe cysticercal meningitis: clinical and imaging characteristics.

Graciela Cárdenas1, Helgi Jung, Camilo Ríos, Agnes Fleury, José Luís Soto-Hernández.   

Abstract

In disease-endemic areas, severe cysticercal meningitis (SCM) is characterized by intense inflammatory cerebrospinal fluid (CSF) and negative bacterial and fungal cultures. There have been no systematic studies of SCM. We characterized patients with SCM and compare them with neurocysticercosis (NC) patients with mild CSF abnormalities by conducting a nine-year retrospective review at a neurological referral center. Two groups of patients were compared: group A, those with severe CSF pleocytosis > 1,000 cells/mm(3) (n = 12), and group B, those with CSF pleocytosis <or= 1,000 cells/mm(3) (n = 126). All patients had positive CSF results in an enzyme-linked immunosorbent assay for cysticercal antigens and negative CSF cultures for bacteria, fungi, and mycobacteria. Intracranial hypertension, meningeal signs, CSF hypoglycorrachia, and a longer clinical course of NC were more frequently seen in group A. It is likely that SCM often goes unrecognized. Its correct identification may reduce morbidity and risks of unnecessary surgery in patients with chronic NC and CSF shunts.

Entities:  

Mesh:

Year:  2010        PMID: 20065006      PMCID: PMC2803520          DOI: 10.4269/ajtmh.2010.09-0347

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  32 in total

1.  [A surprising aglycorrachia! A case of neurocysticercosis].

Authors:  D Cheillan; J Bancel; C Tiliket; J Savet; C Caudie; R Later; A Vighetto
Journal:  Ann Biol Clin (Paris)       Date:  1999-05       Impact factor: 0.459

2.  Neurocysticercosis presenting as chronic meningitis.

Authors:  U C Goel; S Bajaj; R Misra
Journal:  J Assoc Physicians India       Date:  1999-10

3.  [A case of lymphocytic meningitis revealing a neurocysticercosis].

Authors:  S Roth; C Pulcini; F Vandenbos; E Bernard; P Delaunay; P Dellamonica
Journal:  Rev Med Interne       Date:  2002-04       Impact factor: 0.728

4.  Monocyte-astrocyte networks and the regulation of chemokine secretion in neurocysticercosis.

Authors:  Jasim Uddin; Hector H Garcia; Robert H Gilman; Armando E Gonzalez; Jon S Friedland
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

5.  Neurocysticercal antigens stimulate chemokine secretion from human monocytes via an NF-kappaB-dependent pathway.

Authors:  Jasim Uddin; Armando E Gonzalez; Robert H Gilman; Hector H Garcia; Manuela Verastegui; Lisa J Moore; Carlton A W Evans; Robert C Read; Jon S Friedland
Journal:  Microbes Infect       Date:  2006-04-21       Impact factor: 2.700

6.  Late-onset eosinophilic chronic meningitis occurring 30 years after Taenia solium infestation in a white Caucasian woman.

Authors:  H Castillo-Iglesias; S Mouly; A Ducros; C Sarfati; A Sulahian; J F Bergmann
Journal:  J Infect       Date:  2005-10-25       Impact factor: 6.072

7.  [Cysticerci-meningitis].

Authors:  F Rogel-Ortiz; M Vera-Pedro
Journal:  Gac Med Mex       Date:  1997 Jul-Aug       Impact factor: 0.302

8.  Acute cysticercal meningitis--missed diagnosis.

Authors:  Devendra Mishra; Suvasini Sharma; Sanjeev Gupta; Manoja Das; Dinesh Chauhan
Journal:  Indian J Pediatr       Date:  2006-09       Impact factor: 1.967

9.  Neurocysticercosos in South-Central America and the Indian subcontinent. A comparative evaluation.

Authors:  G Singh
Journal:  Arq Neuropsiquiatr       Date:  1997-09       Impact factor: 1.420

10.  Multilevel intramedullary spinal neurocysticercosis with eosinophilic meningitis.

Authors:  Amir M Torabi; Mary Quiceno; Dianne B Mendelsohn; Craig M Powell
Journal:  Arch Neurol       Date:  2004-05
View more
  6 in total

1.  Cranial hypertrophic pachymeningitis secondary to neurocysticercosis.

Authors:  Thiago Cardoso Vale; Helena Duani; Daniela Lino Macedo; Paulo Pereira Christo
Journal:  Neurol Sci       Date:  2012-03-09       Impact factor: 3.307

Review 2.  Diagnosis and treatment of neurocysticercosis.

Authors:  Theodore E Nash; Hector H Garcia
Journal:  Nat Rev Neurol       Date:  2011-09-13       Impact factor: 42.937

3.  Extraparenchymal neurocysticercosis in the United States: a case report.

Authors:  Theodoros Kelesidis; Sotirios Tsiodras
Journal:  J Med Case Rep       Date:  2011-08-09

4.  New diagnostic criteria for neurocysticercosis: Reliability and validity.

Authors:  Arturo Carpio; Agnès Fleury; Matthew L Romo; Ronaldo Abraham; Jaime Fandiño; Juan C Durán; Graciela Cárdenas; Jorge Moncayo; Cleonísio Leite Rodrigues; Daniel San-Juan; Marcos Serrano-Dueñas; Oswaldo Takayanagui; Josemir W Sander
Journal:  Ann Neurol       Date:  2016-08-13       Impact factor: 10.422

Review 5.  Parasitic diseases of the central nervous system: lessons for clinicians and policy makers.

Authors:  Arturo Carpio; Matthew L Romo; R M E Parkhouse; Brooke Short; Tarun Dua
Journal:  Expert Rev Neurother       Date:  2016-03-04       Impact factor: 4.618

6.  Clinical Symptoms, Imaging Features and Cyst Distribution in the Cerebrospinal Fluid Compartments in Patients with Extraparenchymal Neurocysticercosis.

Authors:  Rodrigo Bazan; Pedro Tadao Hamamoto Filho; Gustavo José Luvizutto; Hélio Rubens de Carvalho Nunes; Newton Satoru Odashima; Antônio Carlos Dos Santos; Jorge Elias Júnior; Marco Antônio Zanini; Agnès Fleury; Osvaldo Massaiti Takayanagui
Journal:  PLoS Negl Trop Dis       Date:  2016-11-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.